Antiaging Quantum Living Cash & Equivalents Growth & History (AAQL)

Antiaging Quantum Living's cash and equivalents was $503,486 for fiscal 2026.

View full Antiaging Quantum Living company overview

Antiaging Quantum Living annual cash and equivalents history

Antiaging Quantum Living annual cash and equivalents

Fiscal yearPeriod endedCash and equivalentsChangeGrowth
20262026-03-31$503,486$132,937+35.88%
20252025-03-31$370,549$203,997+122.48%
20242024-03-31$166,552$166,198+46948.59%
20232023-03-31$354−$13,915−97.52%
20222022-03-31$14,269−$3,227−18.44%
20212021-03-31$17,496−$43,975−71.54%
20202020-03-31$61,471$57,330+1384.45%
20192019-03-31$4,141$2,630+174.06%
20182018-03-31$1,511−$124−7.58%
20172017-03-31$1,635

Antiaging Quantum Living cash and equivalents trends

Over the last five fiscal years, Antiaging Quantum Living's cash and equivalents increased from $17,496 to $503,486, a change of $485,990. The latest reported quarter, Q1 2027, shows $608,100.

About the metric

What cash and equivalents mean

Cash and cash equivalents, often described as cash on hand, are highly liquid resources available for near-term obligations, investment, acquisitions, debt repayment, dividends, or share repurchases. This measure does not include short-term investments reported separately.

Calculation and source

Reported cash and equivalents

TickerStat standardizes cash and cash equivalents reported on the balance sheet. Restricted cash is included only when the company reports it within the selected consolidated cash concept. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Antiaging Quantum Living source filings ↗

Community posts

It’s quiet here.

No posts about AAQL yet. Start the conversation.

Write the first post